SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

Marzano sworn in as NRC commissioner

January 10, 2025, 6:55AMNuclear News

Matthew Marzano became the newest member of the Nuclear Regulatory Commission when he was officially sworn into office by chair Christopher Hanson this week.The nuclear engineer and former...

Oklo and Switch partner on nuclear

January 6, 2025, 9:31AMNuclear News

Advanced nuclear company Oklo and data center developer Switch closed out 2024 by announcing a new partnership to deploy 12 GW of advanced nuclear power under a master power agreement....